Location History:
- Jiangsu, CN (2019 - 2023)
- Suzhou, CN (2017 - 2024)
Company Filing History:
5 out of 9 
5 out of 7 
4 out of 8 Years Active: 2017-2025
Title: Innovator Spotlight: Xiaoxiao Wang
Introduction: Xiaoxiao Wang, a prominent inventor based in Jiangsu, China, has made significant strides in the field of medical biology with a notable portfolio of 12 patents. His innovative work primarily focuses on the development of single domain antibodies and proteinaceous heterodimers, showcasing his dedication to advancing therapeutic options for critical health conditions.
Latest Patents: Two of Wang's latest patents include the invention of a single domain antibody and derivative proteins against CTLA4. This invention pertains to medical biology and involves a CTLA4 binding protein, particularly aimed at treating and/or preventing diseases associated with CTLA4, including various tumors. Additionally, he has patented proteinaceous heterodimers, along with pharmaceutical compositions, methods for producing them, and their potential uses in medical applications.
Career Highlights: Throughout his career, Xiaoxiao Wang has been affiliated with leading biopharmaceutical companies, including Dingfu Biotarget Co., Ltd. and Suzhou Alphamab Co., Ltd. His work in these organizations demonstrates his valuable expertise in the development of groundbreaking medical solutions.
Collaborations: Wang has collaborated with esteemed colleagues such as Ting Xu and Yan Luan, contributing to a dynamic environment that fosters innovation and scientific advancement in the realm of biotechnology and pharmacology.
Conclusion: Xiaoxiao Wang's contributions to the field of medical biology illustrate the impact of dedicated inventors in developing revolutionary treatments for complex diseases. With a strong track record of patents and collaborations, Wang continues to play a crucial role in shaping the future of healthcare.